Cargando…

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin

Detalles Bibliográficos
Autores principales:	Kim, Ahwon, Keam, Bhumsuk, Cheun, Hyeon, Lee, Soon-Tae, Gook, Hyung Seok, Han, Moon-Ku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136/ https://www.ncbi.nlm.nih.gov/pubmed/30877699 http://dx.doi.org/10.3988/jcn.2019.15.2.259

Ejemplares similares

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor
por: Chang, Hyeyeon, et al.
Publicado: (2020)

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience
por: Kinsella, JA, et al.
Publicado: (2018)

346. Eastern Equine Encephalitis and Use of Intravenous Immunoglobulin Therapy and High-Dose Steroids
por: Collens, Sarah I, et al.
Publicado: (2020)

Improvement in Primary Autoimmune Myelofibrosis Following a Short Course of Steroids and Intravenous Immunoglobulins
por: Prakash, Swathi, et al.
Publicado: (2022)

Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
por: Li, Tao-Ran, et al.
Publicado: (2020)

Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
por: Shimoni, Z, et al.
Publicado: (2001)

The Laboratory Diagnosis of Autoimmune Encephalitis
por: Lee, Sang Kun, et al.
Publicado: (2016)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Streptococcus Pneumoniae-Related Hemophagocytic Lymphohistiocytosis Treated with Intravenous Immunoglobulin (IVIG) and Steroids
por: Dumancas, Carissa Y., et al.
Publicado: (2018)

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis
por: Schneider, Stephanie, et al.
Publicado: (2017)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021)

Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Park, Ji Eun, et al.
Publicado: (2023)

Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
por: Connery, Kathleen, et al.
Publicado: (2018)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Acute syndrome of apoptotic pan-epidermolysis successfully treated with intravenous immunoglobulin and steroid combination
por: Şentürk, Nilgun, et al.
Publicado: (2022)

Eastern equine encephalitis and use of IV immunoglobulin therapy and high-dose steroids
por: Wilcox, Douglas R., et al.
Publicado: (2020)

POSTINFECTIOUS COVID-19 ENCEPHALITIS RESPONSIVE TO PULSE-DOSE STEROIDS AND IV IMMUNOGLOBULINS
por: HALANI, VARUN, et al.
Publicado: (2022)

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020)

Treatment strategies for autoimmune encephalitis
por: Shin, Yong-Won, et al.
Publicado: (2017)

Efficacy of add‐on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome
por: Sim, Da Woon, et al.
Publicado: (2021)

Intravenous immunoglobulins in infantile dyshidrosiform bullous pemphigoid refractory to steroids and dapsone
por: Viglizzo, Gianmaria, et al.
Publicado: (2022)

596 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
por: Alyoshkin, Vladimir
Publicado: (2012)

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
por: Dourmishev, Lyubomir A., et al.
Publicado: (2016)

Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer
por: Yoo, Shin Hye, et al.
Publicado: (2018)

Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy
por: Kim, Miso, et al.
Publicado: (2015)

Proportion of peripheral regulatory T cells in patients with autoimmune encephalitis
por: Byun, Jung-Ick, et al.
Publicado: (2021)

Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions
por: Georgiadou, Sarah, et al.
Publicado: (2019)

Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review
por: Wagner, Judith N., et al.
Publicado: (2021)

Autoimmune Encephalitis as an Adverse Event of COVID-19 Vaccination
por: Shin, Hye-Rim, et al.
Publicado: (2022)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: Oh, So Yeon, et al.
Publicado: (2021)

Intravenous Immunoglobulin Therapy for Persistent Pemphigoid Gestationis with Steroid Induced Iatrogenic Cushing's Syndrome
por: Ko, Bum Joon, et al.
Publicado: (2014)

A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins
por: Dimala, Christian Akem, et al.
Publicado: (2021)

Two PerPLEXing Cases of Hashimoto’s Encephalopathy Unresponsive to Steroid and Intravenous Immunoglobulin Therapy
por: Karan, Abhinav, et al.
Publicado: (2022)

Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
por: Massa, Federico, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mt075isp6jmn5ntebbi6rkpoq7